Evoxac - Cevimeline - Dosage - Side Effects - Interactions - Warnings
Evoxac (Cevimeline HCI) drug information, dosage, side effects, drug interactions, and warnings. Evoxac, generic drug name Cevimeline HCI, is used to treat dry mouth symptoms in conditions such as Sjogren's syndrome. Cevimeline capsules (Evoxac) help to increase saliva and decrease dry mouth symptoms in patients with Sjogren's syndrome.
Dry Mouth - Guide to Dry Mouth
Dry mouth can be a sign of certain diseases and conditions such as Sjogren's syndrome. Dry mouth is not a normal part of aging. Dry mouth is more than uncomfortable, it can lead to serious health problems.
Dry mouth can be a sign of certain diseases and conditions such as Sjogren's syndrome. Dry mouth is not a normal part of aging. Dry mouth is more than uncomfortable, it can lead to serious health problems.
Sjogren's Syndrome Screening Quiz
Sjogren's syndrome can occur as a primary condition or a secondary condition. Take our screening quiz and see if you have symptoms associated with Sjogren's syndrome.
Sjogren's syndrome can occur as a primary condition or a secondary condition. Take our screening quiz and see if you have symptoms associated with Sjogren's syndrome.
Guide to Sjogren's Syndrome
Sjogren's syndrome is an autoimmune disease. In Sjogren's syndrome, the immune system targets moisture-producing glands and causes dryness in the mouth and eyes. Other parts of the body can be affected as well, resulting in a wide range of possible symptoms.
Sjogren's syndrome is an autoimmune disease. In Sjogren's syndrome, the immune system targets moisture-producing glands and causes dryness in the mouth and eyes. Other parts of the body can be affected as well, resulting in a wide range of possible symptoms.
Consumer Information: Evoxac
Evoxac, approved by the FDA in January 2000, is used to treat dry mouth in people with Sjogren’s Syndrome, from FDA.
Evoxac, approved by the FDA in January 2000, is used to treat dry mouth in people with Sjogren’s Syndrome, from FDA.
Evoxac (cevimeline HCI) 30 mg capsules
Evoxac(cevimeline HCI) 30 mg capsules, is FDA approved for the treatment of dry mouth symptoms in patients with Sjögren's syndrome. This product was introduced in 2000, and is marketed and distributed in the US by Daiichi Pharmaceutical, from Evoxac.com
Evoxac(cevimeline HCI) 30 mg capsules, is FDA approved for the treatment of dry mouth symptoms in patients with Sjögren's syndrome. This product was introduced in 2000, and is marketed and distributed in the US by Daiichi Pharmaceutical, from Evoxac.com